Press Release: Avid Radiopharmaceuticals : Lilly Joins the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS) Study

INDIANAPOLIS, Oct. 7, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced financial commitment and continued scientific partnership to support the recently established Imaging Dementia -...